4.7 Article

Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Radiology, Nuclear Medicine & Medical Imaging

18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation

Felix G. Gassert et al.

Summary: The study analyzed the cost-effectiveness of using whole-body F-18 FDG PET/MRI as an alternative imaging method for the initial staging of rectal cancer, and found that it could be a feasible diagnostic strategy with potential economic advantages.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible?

Jelena Djokic Kovac et al.

ACADEMIC RADIOLOGY (2019)

Review Oncology

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Prashanth Rawla et al.

WORLD JOURNAL OF ONCOLOGY (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Chong Hyun Suh et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2018)

Review Public, Environmental & Occupational Health

On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review

David Cameron et al.

GLOBAL HEALTH ACTION (2018)

Article Medicine, General & Internal

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

T. Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Surgery

Pancreatic Cancer Surgery The New R-status Counts

Oliver Strobel et al.

ANNALS OF SURGERY (2017)

Review Medicine, General & Internal

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine

Gillian D. Sanders et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Article Gastroenterology & Hepatology

Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argument

Jeffrey M. Sutton et al.

Article Oncology

Costs and Trends in Pancreatic Cancer Treatment

Caitriona B. O'Neill et al.

CANCER (2012)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

Metastatic patterns in adenocarcinoma

KR Hess et al.

CANCER (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

Pancreatic cancer: Cost-effectiveness of imaging technologies for assessing resectability

PM McMahon et al.

RADIOLOGY (2001)

Article Surgery

Quality of life and outcomes after pancreaticoduodenectomy

JJ Huang et al.

ANNALS OF SURGERY (2000)